Computational pathology in bladder cancer: A scoping review
Bladder Cancer · 2026-01 · 12 (1)
DOI: 10.1177/23523735251413333 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bladder Cancer, online erschienen am 26.02.2026. Verfasst von Michael Superdock und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute (NCI), National Institutes of Health, Advanced Research Projects Agency for Health.
Abstract (Originalsprache)
Background
Histologic assessment of tumor tissue is fundamental to the diagnosis and management of bladder cancer. As digital pathology becomes more widely adopted and artificial intelligence (AI) tools rapidly advance, computational pathology has emerged as a promising avenue for extracting clinically meaningful information from pathology images.
Objectives
This scoping review aims to provide a comprehensive overview of the current landscape of computational pathology in bladder cancer. We describe the commonly used AI and machine learning approaches for analyzing whole slide images (WSIs) and summarize their use in diagnosis, grading, staging, molecular classification, prognostication, and treatment response prediction in bladder cancer.
Methods
This review was conducted in accordance with PRISMA-ScR 2018 guidelines. We searched PubMed/MEDLINE for primary research articles focused on computational or AI-based analysis of human bladder cancer histopathology images across predefined predictive tasks. Eligible studies underwent full-text review. Findings were synthesized narratively by task.
Results
A total of 2055 abstracts were screened. Fifty-three studies met eligibility criteria and were included in the review.
Conclusions
Computational pathology offers substantial promise for augmenting pathologist workflows and advancing personalized care in bladder cancer. Current studies remain largely retrospective, but there is a rapid pace of innovation and a clear opportunity to work towards real-world clinical implementation. Establishing shared multi-institutional datasets and standardized evaluation frameworks could help support future research and expedite clinical implementation of computational pathology tools for bladder cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- School of Data Science and Society, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
ORCID-Profile: Michael Superdock
Förderung
- NCI NIH HHS
- National Cancer Institute (NCI), National Institutes of Health
- Advanced Research Projects Agency for Health
- Thomas M. Mohr Fund for Bladder Cancer Research
- The John William Pope Foundation
Zitieren
APA
Superdock, M., Wobker, S. E., Carmicheal, I., & Kim, W. Y. (2026). Computational pathology in bladder cancer: A scoping review. Bladder Cancer, 12(1). https://doi.org/10.1177/23523735251413333
Vancouver
Superdock M, Wobker SE, Carmicheal I, Kim WY. Computational pathology in bladder cancer: A scoping review. Bladder Cancer. 2026;12(1). doi:10.1177/23523735251413333
BibTeX
@article{Superdock2026,
author = {Superdock, Michael and Wobker, Sara E and Carmicheal, Iain and Kim, William Y},
title = {Computational pathology in bladder cancer: A scoping review},
journal = {Bladder Cancer},
year = {2026},
volume = {12},
number = {1},
doi = {10.1177/23523735251413333}
}
EUVIMED